MARKET

MRK

MRK

Merck & Co
NYSE
143.37
-1.09
-0.75%
Pre Market: 142.40 -0.97 -0.68% 08:08 11/18 EST
OPEN
143.32
PREV CLOSE
144.46
HIGH
144.89
LOW
142.31
VOLUME
789
TURNOVER
--
52 WEEK HIGH
156.00
52 WEEK LOW
89.48
MARKET CAP
353.44B
P/E (TTM)
146.27
1D
5D
1M
3M
1Y
5Y
1D
Merck says Thomas Glocer to retire from board of directors
TipRanks · 3h ago
Merck Discontinues Nemtabrutinib Program Following Review Of Phase 3 Trial Data
NASDAQ · 6h ago
Trump abandons Heidi Overton as FDA commissioner nominee: reports
Seeking Alpha · 11h ago
Merck ends development of BTK inhibitor nemtabrutinib
Seeking Alpha · 17h ago
Merck Ends Development of Blood Cancer Drug Nemtabrutinib
Dow Jones · 17h ago
Merck announces discontinuation of development program evaluating MK-1026
TipRanks · 17h ago
United States no longer considered a measles-eliminated country
Seeking Alpha · 21h ago
Merck raises dividend by 3.5% to $0.88
Seeking Alpha · 22h ago
More
About MRK
Merck & Co., Inc. is a global health care company that delivers health solutions through its prescription medicines, including biologic therapies, vaccines and animal health products. Its Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Company sells its human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers. It sells these human health vaccines primarily to physicians, wholesalers, distributors and government entities. Its Animal Health segment discovers, develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all livestock and companion animal species. Its products include KEYTRUDA (pembrolizumab) injection, for intravenous use; WELIREG (belzutifan) tablets, for oral use; Ohtuvayre (ensifentrine) and others.

Webull offers Merck & Co Inc stock information, including NYSE: MRK real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MRK stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MRK stock methods without spending real money on the virtual paper trading platform.